Swedish Orphan Biovitrum AB (publ) (SWOBY)
OTCMKTS · Delayed Price · Currency is USD
15.75
0.00 (0.00%)
At close: Aug 25, 2025
SWOBY Market Cap
SWOBY has a market cap or net worth of $10.60 billion as of August 26, 2025. Its market cap has increased by 16.98% in one year.
Market Cap
10.60B
Enterprise Value
11.83B
Revenue
2.84B
Ranking
n/a
PE Ratio
23.06
Stock Price
$15.75
Market Cap Chart
Since September 15, 2006, SWOBY's market cap has increased from 663.04M to 10.60B, an increase of 1,498.90%. That is a compound annual growth rate of 15.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2025 | 10.60B | 6.23% |
| Dec 30, 2024 | 9.98B | 9.75% |
| Dec 29, 2023 | 9.09B | 46.56% |
| Dec 30, 2022 | 6.20B | 1.41% |
| Dec 30, 2021 | 6.12B | 2.35% |
| Dec 30, 2020 | 5.98B | 22.62% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 636.43M |
| Elite Pharmaceuticals | 586.30M |
| CytoDyn | 388.66M |
| Northwest Biotherapeutics | 357.21M |
| American Oncology Network | 357.05M |